Emerging trends in anticancer therapy include immunotherapy, which harnesses the body's immune system to target cancer cells. While promising, these therapies can also lead to unique toxicities like immune-related adverse events. Additionally, the development of nanoparticles for drug delivery aims to enhance targeting and reduce systemic toxicity.
